首页> 外文OA文献 >Propensity-score-matched comparative analyses of simultaneously administered fixed-ratio insulin glargine 100 U and lixisenatide (iGlarLixi) vs sequential administration of insulin glargine and lixisenatide in uncontrolled type 2 diabetes

【2h】

Propensity-score-matched comparative analyses of simultaneously administered fixed-ratio insulin glargine 100 U and lixisenatide (iGlarLixi) vs sequential administration of insulin glargine and lixisenatide in uncontrolled type 2 diabetes

机译：在不受控制的2型糖尿病中，同时给药的固定比胰岛素狼糖蛋白100u和Lixisenatide（Iglarlixi）对胰岛素狼肽和Lixisenatide的连续施用胰岛素的比较分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Julio Rosenstock; Yehuda Handelsman; Josep Vidal; F. Javier Ampudia Blasco; Francesco Giorgino; Minzhi Liu; Riccardo Perfetti; Juris J. Meier;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Propensity‐score‐matched comparative analyses of simultaneously administered fixed‐ratio insulin glargine 100?U and lixisenatide (iGlarLixi) vs sequential administration of insulin glargine and lixisenatide in uncontrolled type 2 diabetes [J] . Rosenstock Julio, Handelsman Yehuda, Vidal Josep, Diabetes, obesity & metabolism . 2018,第12期

机译：同时给药的固定比率胰岛素狼氨素100β的倾向分数匹配比较分析
2. Impact of baseline glycated haemoglobin, diabetes duration and body mass index on clinical outcomes in the LixiLan-O trial testing a titratable fixed-ratio combination of insulin glargine/lixisenatide (iGlarLixi) vs insulin glargine and lixisenatide monocomponents [J] . Davies Melanie J., Leiter Lawrence A., Guerci Bruno, Diabetes, obesity & metabolism . 2017,第12期

机译：基线糖化血红蛋白，糖尿病持续时间和体重指数对莱西兰 - o试验中可滴注的固定比组合（Iglarllixi）与胰岛素狼生物和Lixisenatide单一组分的肝脏试验中的临床结果对脑兰 - o试验的影响
3. Consistent findings in glycaemic control, body weight and hypoglycaemia with iGlarLixi (insulin glargine/lixisenatide titratable fixed-ratio combination) vs insulin glargine across baseline HbA1c, BMI and diabetes duration categories in the LixiLan-L trial [J] . Wysham Carol, Bonadonna Riccardo C., Aroda Vanita R., Diabetes, obesity & metabolism . 2017,第10期

机译：血糖控制，体重和低血糖与Iglarlixi（胰岛素狼蛛/ Lixisenatide滴定定义的组合）在基线HBA1C，BMI和糖尿病持续时间在Lixilan-L试验中的胰岛素糖尿病中的一致结果
4. TITLE: 6-month administration of Oral Insulin at Lunchtime in Juvenile Type-1 DM Subjects on Basal Glargine Insulin and Pre-Breakfast and Pre-Dinner Regular Insulin [C] . Jaime Guevara-Aguirre, Marco Guevara-Aguirre, Jeannette Saavedra, Controlled Release Society Annual Meeting and Exposition . 2007

机译：标题：午餐时间为1型DM少年受试者接受基础甘草碱胰岛素和早餐前和晚餐前常规胰岛素的口服胰岛素治疗，为期6个月
5. Physiology and pharmacology of diabetes therapies in the cat: Insulin detemir, insulin glargine, exenatide and the incretin effect. [D] . Gilor, Chen. 2010

机译：猫的糖尿病疗法的生理和药理作用：地特胰岛素，甘精胰岛素，艾塞那肽和肠降血糖素作用。
6. Propensity‐score‐matched comparative analyses of simultaneously administered fixed‐ratio insulin glargine 100 U and lixisenatide (iGlarLixi) vs sequential administration of insulin glargine and lixisenatide in uncontrolled type 2 diabetes [O] . Julio Rosenstock, Yehuda Handelsman, Josep Vidal, -1

机译：在不受控制的2型糖尿病患者中同时施用固定比例的甘精胰岛素和利西拉肽（iGlarLixi）与序贯施用甘精胰岛素和利西拉肽的倾向得分匹配比较分析
7. Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial. [O] . Rosenstock, J., Aronson, R., Grunberger, G., 2016

机译：LixiLan的可滴定固定比例胰岛素口服组合物的可控固定比例组合在口服药物控制不充分的2型糖尿病中的作用与胰岛素甘草碱和Lixisenatide单组分的比较：LixiLan-O随机试验。

Propensity-score-matched comparative analyses of simultaneously administered fixed-ratio insulin glargine 100 U and lixisenatide (iGlarLixi) vs sequential administration of insulin glargine and lixisenatide in uncontrolled type 2 diabetes

著录项

相似文献

相关主题

期刊订阅